Wilson Marc 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Tax Payment
Common Stock
2024-03-18$38.14/sh−3,983$151,912→ 117,572 total - Sale
Common Stock
2024-03-19$42.91/sh−6,942$297,881→ 110,630 total
Footnotes (3)
- [F1]Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022 and March 1, 2023. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.
- [F3]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $42.91 per share. The range of sales prices on the transaction date was $41.04 to $44.00 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.